Know Cancer

or
forgot password
  • cancer clinical trials in madison, WI

  • Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Gastric Cancer
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
    Veterans Affairs Medical Center - Madison

    Trial Locations
    Veterans Affairs Medical Center - Madison
    University of Wisconsin Comprehensive Cancer Center
    Multiple Myeloma, Plasma Cell Neoplasm
    Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Brain and Central Nervous System Tumors
    Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
    Dean Medical Center - Fish Hatchery
    Madison, Wisconsin 53715
    Breast Cancer
    3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Unspecified Adult Solid Tumor, Protocol Specific
    hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Neuroblastoma
    N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Neuroblastoma
    STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
    University of Wisconsin Medical School
    Madison, Wisconsin 53792-0001
    Melanoma
    Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Unspecified Adult Solid Tumor, Protocol Specific
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Endometrial Cancer
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Non-Small Cell Lung Cancer
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Biliary Tract Cancer
    Levocarnitine in Treating Fatigue in Cancer Patients
    Dean Medical Center - Madison

    Trial Locations
    Dean Medical Center - Madison
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Mesothelioma
    Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Lung Cancer
    Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Lymphoma
    OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
    University of Wisconsin Medical School
    Madison, Wisconsin 53792-0001
    Pain, Cancer
    AP23573 in Patients With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(8669-017)(COMPLETED)
    University of Wisconsin, Madison, WI
    Madison, Wisconsin 53792
    Prostate Cancer
    Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Sarcoma
    Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Brain and Central Nervous System Tumors
    Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Sarcoma
    Genistein in Patients Who Are Undergoing Surgery for Bladder Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Bladder Cancer
    Study of Satraplatin (JM-216) in Combination With Docetaxel
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Tumors
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    University of Wisconsin Medical School: Clinical Trials
    Madison, Wisconsin 53715
    Prostate Cancer, Osteoporosis, Fractures
    ATN-161 in Advanced Renal Cell Cancer
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Carcinoma, Renal Cell
    EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide
    University of Wisconsin Division of Gynecologic Oncology
    Madison, Wisconsin 53792
    Ovarian Cancer, Colorectal Cancer, Carcinoma, Non-Small-Cell Lung, Prostate Cancer
    Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Lung Cancer
    Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Renal Transplantation
    A Phase III Trial For Patients With Metastatic Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician.
    Madison, Wisconsin
    Breast Cancer, Breast Neoplasms, Cancer of the Breast
    Surveillance For New Lung Primaries
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Lung Cancer
    Surveillance For New Lung Primaries
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Lung Cancer
    MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors
    University Of Wisconsin Comprehensive Center
    Madison, Wisconsin 53792
    Tumors, Neoplasm Metastasis
    Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Ovarian Carcinoma, Primary Peritoneal Carcinoma
    Hypofractionated Radiotherapy for Lung Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Lung Cancer
    Multi-catheter High Dose Rate (HDR) Breast Brachytherapy
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Breast Cancer
    Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Glioma, Brain Neoplasms
    Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Lymphoma
    Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Brain Metastasis, Non-small Cell Lung Cancer
    Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Unspecified Adult Solid Tumor, Protocol Specific
    Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Lymphoma
    Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Recurrent Adult Acute Lymphoblastic Leukemia
    Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Colorectal Cancer, Metastatic Cancer
    Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
    Dean Hematology and Oncology Clinic
    Madison, Wisconsin 53717
    Recurrent Melanoma, Stage IV Melanoma
    Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
    University of Wisconsin, Madison
    Madison, Wisconsin 53792
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain
    University of Wisconsin School of Medicine
    Madison, Wisconsin
    Neurotoxicity, Pain, Breast Cancer
    Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Congenital Amegakaryocytic Thrombocytopenia, Diamond-blackfan Anemia, Leukemia, Myelodysplastic Syndromes, Severe Congenital Neutropenia
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Brain and Central Nervous System Tumors
    Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Lung Cancer
    Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Cancer
    A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer
    University Of Wisconsin Hospital And Clinics Laboratory
    Madison, Wisconsin 53792
    Prostate Cancer
    Ixabepilone, Mitoxantrone Hydrochloride, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy and Chemotherapy
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Lymphoma
    PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    Belinostat in Treating Patients With Myelodysplastic Syndromes
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Secondary Myelodysplastic Syndromes
    Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy
    University of Wisconsin Hospital & Clinics
    Madison, Wisconsin 53792
    Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor, Pancreatic Neoplasms
    Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers
    University of Wisconsin- Madison 610 Walnut St, WARF 1109A
    Madison, Wisconsin 53705
    Non-Small Cell Lung Cancer
    Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease
    University of Wisconsin Madison
    Madison, Wisconsin 53792
    Graft Versus Host Disease
    Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Sarcoma
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia